Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Group A and C meningococcal conjugate vaccine schedules in 12–23‑month-old children
CTR20232302Phase 4Active
- Sponsor
- Olin Biological
- Start
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group A and C conjugate vaccine in meningococcal meningitis, sponsored by Olin Biological. Started Aug 2023; status: active.
02
Drugs
meningococcal group A and C conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20232302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232302.